The Vice President of Research and Development at a pharmaceutical company oversees the entirety of the company’s drug discovery and development engine. From early-stage target identification through clinical development and regulatory submission, the VP R&D manages a portfolio of programs that represent the company’s future commercial value. The breadth and technical complexity of this role create PA support demands that are distinctive within the pharmaceutical industry: requiring a combination of scientific literacy, operational organization, and stakeholder management skills that few other executive support roles demand.
The VP R&D’s Scope of Responsibility
The pharmaceutical VP R&D typically oversees research (drug discovery and preclinical work), clinical development (Phase I through Phase III trials), regulatory affairs, pharmacovigilance, and often biostatistics and data management. In some organizational structures, medical affairs also reports to the VP R&D.
This scope means the VP R&D’s stakeholder universe spans the internal scientific organization, external academic collaborators, clinical investigators, regulatory agencies, the scientific advisory board, and the senior executive team. Managing this stakeholder universe effectively requires a PA who understands the different cadences and priorities of each group and can coordinate across them without the VP R&D needing to be the communication hub for every interaction.
Research Portfolio Management Support
The VP R&D manages a portfolio of research programs ranging from early-stage target exploration to advanced preclinical candidates. Portfolio management involves regular reviews of program status, resource allocation decisions, and go/no-go decisions at development milestones. The PA supports the research portfolio management process by:
Scheduling and coordinating the preparation for regular portfolio review meetings, which may include monthly research steering committee meetings, quarterly pipeline reviews, and annual strategic portfolio assessments. Managing the document preparation process for these reviews, including coordinating scientific updates from program leads, formatting materials, and ensuring that decision-relevant information is clearly presented.
Tracking action items from portfolio reviews and following up with program teams to ensure that decisions made in review meetings translate into action. This follow-up discipline is essential for maintaining the momentum of portfolio management processes.
Clinical Development Governance
Clinical development programs require ongoing governance to ensure that they are proceeding according to plan, that safety monitoring is adequate, and that the data emerging from ongoing trials is guiding appropriate program decisions. The VP R&D chairs or participates in clinical development governance bodies including development review committees, data review teams, and cross-functional project teams.
The PA manages the logistics of clinical development governance meetings, coordinating schedules across medical, regulatory, biostatistics, and clinical operations teams, managing the preparation and distribution of meeting materials, and tracking follow-up actions from clinical review meetings.
External Scientific Collaboration Management
Pharmaceutical VPs R&D maintain relationships with academic collaborators, research institution partners, and scientific advisors that are important for both scientific insight and talent development. Managing these external collaborations requires regular coordination with universities, research hospitals, and individual investigators.
The PA supports external collaboration management by scheduling collaboration meetings and visits, coordinating the logistics of collaborative research committee meetings, managing correspondence with academic partners, and tracking the deliverable and reporting obligations in collaborative research agreements.
Regulatory Affairs Coordination
The VP R&D oversees regulatory affairs and is responsible for the company’s regulatory strategy and interactions with FDA, EMA, and other agencies. Regulatory interactions require intensive coordination, and the PA supports this by managing the regulatory meeting calendar, coordinating preparation for regulatory meetings, and ensuring that the VP R&D is briefed on pending regulatory decisions and responses.
The PA works closely with the regulatory affairs team to maintain an accurate picture of the regulatory calendar, including submission deadlines, expected FDA response dates, and the schedule of formal regulatory meetings. This regulatory calendar management is one of the most consequential aspects of supporting the VP R&D.
Scientific Conference Engagement
VPs R&D attend and often speak at major scientific and medical conferences in their therapeutic areas. The PA manages conference attendance, including abstract submission logistics, speaking invitation responses, travel coordination, and the preparation of presentation materials.
For conferences where the company is presenting clinical data, the PA coordinates with the communications and IR teams to ensure that the presentation logistics are integrated with the company’s data communication strategy.
Managing the R&D Budget
The VP R&D manages a substantial budget that covers research programs, clinical trial costs, regulatory activities, and personnel. The PA supports budget management by tracking spending against plan, coordinating the annual budget planning process, and ensuring that the VP R&D has timely access to financial performance reports.
For specific high-cost clinical programs, the PA may support the preparation of budget variance analyses that explain deviations from plan to the CFO and board.
For a comprehensive view of PA responsibilities across pharmaceutical executive roles, see pharma PA duties. The pharma CEO assistant guide provides additional context on executive support in pharmaceutical organizations.
Conclusion
Supporting a pharmaceutical VP of Research and Development requires a PA who can operate effectively at the intersection of scientific rigor and operational discipline. The combination of scientific portfolio management, clinical governance oversight, regulatory coordination, and external relationship management that defines the VP R&D role creates PA demands that are among the most intellectually demanding in the pharmaceutical executive support field. PAs who develop genuine expertise in pharmaceutical R&D become indispensable partners in the work of advancing medicines from discovery to patients.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.